Resmed (RSMDF) Cash from Operations (2009 - 2026)

Resmed (RSMDF) has reported Cash from Operations for 18 consecutive years, with $454.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cash from Operations fell 15.62% year-over-year to $454.6 million; the trailing twelve-month figure through Jun 2026 stood at $1.8 billion (up 3.1% YoY), and the FY2026 full-year result was $1.8 billion, up 3.1% from the prior year.
• Cash from Operations slipped to $454.6 million in Q2 2026 per RSMDF's latest filing, from $554.1 million in the prior quarter.
• Across five years, Cash from Operations topped out at $578.7 million in Q1 2025 and bottomed at $44.7 million in Q3 2022.
• Historically, Cash from Operations has averaged $324.9 million across 5 years, with a median of $317.1 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Cash from Operations slumped 64.91% in 2022, then soared 541.0% in 2023.
• Over 5 years, Cash from Operations stood at $128.6 million in 2022, then jumped by 112.1% to $272.8 million in 2023, then grew by 13.12% to $308.6 million in 2024, then advanced by 10.08% to $339.7 million in 2025, then soared by 33.82% to $454.6 million in 2026.
• According to Business Quant data, Cash from Operations over the past three periods registered $454.6 million, $554.1 million, and $339.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.